A detailed history of Intrepid Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Intrepid Capital Management Inc holds 7,118 shares of JNJ stock, worth $1.04 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
7,118
Previous 6,536 8.9%
Holding current value
$1.04 Million
Previous $955,000 20.73%
% of portfolio
0.84%
Previous 0.78%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $84,669 - $97,415
582 Added 8.9%
7,118 $1.15 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $545,467 - $596,092
3,778 Added 136.98%
6,536 $955,000
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $39,736 - $41,661
256 Added 10.23%
2,758 $436,000
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $164,673 - $179,693
1,131 Added 82.49%
2,502 $392,000
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $26,789 - $30,010
-172 Reduced 11.15%
1,371 $213,000
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $31,641 - $34,052
205 Added 15.32%
1,543 $255,000
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $46,221 - $55,159
-306 Reduced 18.61%
1,338 $207,000
Q4 2022

Feb 06, 2023

BUY
$160.2 - $179.79 $5,607 - $6,292
35 Added 2.18%
1,644 $290,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $40,171 - $44,700
249 Added 18.31%
1,609 $263,000
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $15,978 - $17,670
95 Added 7.51%
1,360 $241,000
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $7,906 - $8,979
50 Added 4.12%
1,265 $224,000
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $189,454 - $210,207
1,215 New
1,215 $208,000
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $263,245 - $292,536
-1,630 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $259,952 - $278,844
1,630 New
1,630 $269,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Intrepid Capital Management Inc Portfolio

Follow Intrepid Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrepid Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Intrepid Capital Management Inc with notifications on news.